NTRK1 and early-onset autosomal dominant Alzheimer disease: By expressing the human neurotrophin receptor TrkA, which is implicated in Alzheimer’s disease, cancer, and other pathologies, on magnetosomes, we created a functional human transmembrane receptor platform that enables magnetic recovery and ligand screening.